Join us at our last conference in 2026 – Cell UK 12th-13th November.
Our teams of experts will be there to answer all your questions, especially about our Recombinant Insulin and TrypsiNNex®.
Our Recombinant Insulin is approved by the FDA and EMA and is a vital ingredient in over 100 therapeutic drugs, revolutionising healthcare worldwide.
TrypsiNNex® is an animal-free, recombinant porcine trypsin that delivers exceptional performance and consistency for highly regulated biopharma manufacturing processes.
